Genomma Lab sets December 3 Investor Day. Target for Genomma Lab stock is MXN 21.33

Published on 10/21/2026 at 10:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Investor Day will show AI agents and operating priorities in New York on December 3, 2026. Genomma Lab stock costs EUR 0.69 on October 21, 2026.

Investor Day sets the timetable

Genomma Lab will host Investor Day on December 3, 2026, in New York.
Second-quarter 2026 revenue reached MXN 4.397 billion and net income was MXN 374.5 million.
Genomma Lab stock trades at EUR 0.69 at 10:37 a.m. CEST at Lang & Schwarz on October 21, 2026.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab (ISIN MX01LA010006) stock was trading at EUR 0.69 at Lang & Schwarz on October 21, 2026 at 10:37 a.m. CEST. The company had announced on October 15, 2026, that it will hold an Investor Day in New York on December 3, 2026, according to PR Newswire.

Investor Day has a date

The event will bring senior management together with institutional investors and sell-side analysts. The agenda includes strategic priorities, growth opportunities, a new operational platform and demonstrations of artificial intelligence agents, while registration closes on November 25, 2026.

Three milestones shape the story

On September 17, 2026, Genomma Lab announced a leadership transition that will bring founder Rodrigo Herrera back as interim CEO in January 2027, according to Genomma Lab. On October 1, 2026, the company scheduled its third-quarter 2026 results for October 21, according to PR Newswire. On October 15, 2026, it set the December 3 Investor Day as the next strategic communication milestone.

What does the plan mean?

The operating backdrop gives the December event a measurable challenge. Genomma Lab reported second-quarter 2026 revenue of MXN 4.397 billion and net income of MXN 374.5 million, while first-quarter revenue was MXN 4.191 billion and net income was MXN 494.6 million, figures listed by Yahoo Finance. The same page showed an average analyst target of MXN 21.33 as of October 20, 2026, against a high of MXN 29.00.

Next dates are set

The company scheduled its third-quarter 2026 earnings release for October 21, 2026, after the Mexican Stock Exchange close, followed by a conference call on October 22, 2026, at 11:00 a.m. Mexico City time. Investor Day follows on December 3, 2026, in New York.

Stock price and company scale

Genomma Lab's market capitalization was MXN 13.95 billion as of October 20, 2026. The company develops and distributes non-prescription pharmaceuticals and personal hygiene products, with 1,465 employees listed in its company profile.

The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.